/RLLVF

RLLVF Stock - Relevium Technologies Inc.

Q: What is the analyst price target for RLLVF?

Analyst price target information is not currently available for RLLVF.

Q: What is RLLVF's market cap?

Market capitalization information is not currently available for RLLVF.

Healthcare|Medical - Pharmaceuticals|OTC

$0.01+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RLLVF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.08

52W High$0.22

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020
Revenue	$913,644	$2.97M
Gross Profit	$414,475	$1.19M
Gross Margin	45.4%	40.2%
Operating Income	$-1,475,457	$-2,771,750
Net Income	$-5,368,336	$-6,931,628
Net Margin	-587.6%	-233.1%
EPS	$-0.03	$-0.04

Company Overview

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

Visit Website

Frequently Asked Questions about RLLVF

What is RLLVF's current stock price?

Relevium Technologies Inc. (RLLVF) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for RLLVF?

No analyst price targets are currently available for this stock.

What sector is Relevium Technologies Inc. in?

Relevium Technologies Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is RLLVF's market cap?

Relevium Technologies Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does RLLVF pay dividends?

No, Relevium Technologies Inc. does not currently pay a dividend to shareholders.